Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time.
Millions of Americans with diabetes need insulin to survive, yet for many of these vulnerable patients, their insulin drug ...
The World Health Organization issued a warning last year about insulin pens relabeled and repackaged to look like Ozempic.
Zacks.com on MSN2d
NVO Stock Loses Around $29B in 3 Months: Buy the Dip or Steer Clear?Novo Nordisk NVO shares have lost 5% in the past three months, which translates to approximately $29 billion in market value, ...
Explosive demand and high prices for Novo Nordisk and Eli Lilly's weight loss and diabetes drugs have fueled a criminal ...
MADRID — Day of the week, age, snacking, and being more engaged with smart insulin pens are important factors that affect ...
J.P. Morgan analyst Richard Vosser maintained a Buy rating on Novo Nordisk (0QIU – Research Report) today and set a price target of ...
Criminals distribute fake Ozempic by forging batch numbers. Novo Nordisk suspects one source in global counterfeiting ...
The Federal Trade Commission (FTC) has filed a legal complaint accusing the 3 largest pharmacy benefit managers (PBMs) in the ...
The Federal Trade Commission said pharmacy benefit managers created a "perverse drug rebate system" that artificially ...
In a report released today, Jo Walton from UBS maintained a Hold rating on Novo Nordisk (0QIU – Research Report), with a price target of ...
The global insulin pens market is experiencing rapid expansion, driven by the rising global prevalence of diabetes. According ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback